PHARMACOKINETICS OF DA-125, A NEW ANTHRACYCLINE, AFTER INTRAVENOUS ADMINISTRATION TO SPONTANEOUSLY HYPERTENSIVE RATS AND DOCA-SALT-INDUCED HYPERTENSIVE RATS
Ej. Yoon et al., PHARMACOKINETICS OF DA-125, A NEW ANTHRACYCLINE, AFTER INTRAVENOUS ADMINISTRATION TO SPONTANEOUSLY HYPERTENSIVE RATS AND DOCA-SALT-INDUCED HYPERTENSIVE RATS, Drug metabolism and disposition, 25(1), 1997, pp. 66-74
Pharmacokinetic parameters-including tissue distribution, biliary excr
etion, and urinary excretion of M1-M4- were compared after an intraven
ous administration of DA-125 (a new anthracycline derivative; 20 mg/kg
body weight) to male spontaneously hypersensitive rats (SHRs) at 16 w
eeks (an animal model for human primary hypertension) and at 6 weeks (
corresponding to the early phase of the development of hypertension, a
t which time blood pressure remains within the normotensive range) of
age and their age-matched control Kyoto-Wistar rats, and male deoxycor
ticosterone acetate-salt-induced Sprague-Dawley rats (DOCA-salt rats,
an animal model for human secondary hypertension) at 16 weeks of age a
nd their age-matched control Sprague-Dawley rats. Mean plasma concentr
ations of both M2 and M4, and the resultant area under the plasma conc
entration-time curve from time 0 to last measured time [AUCT; M2 (68.9
vs. 29.3 mu g-min/ml) and M4 (53.4 vs. 33.4 mu g-min/ml)], increased
significantly in SHRs at 16 weeks of age, compared with their control
rats. Similar results were also obtained from DOCA-salt rats at 16 wee
ks of age, compared with their control rats. However, values were not
significantly different between SHRs at 6 weeks of age and their contr
ol rats. Previous data indicated that the significant increase in plas
ma concentrations and the resultant AUCT values of both M2 and M4 in S
HRs at 16 weeks of age were due to the hypertension state itself, and
not to any hereditary characteristics of the SHRs, The significantly i
ncreased plasma concentrations and the resultant AUCT values of M2 in
both SHRs and DOCA-salt rats at 16 weeks of age were due to the signif
icantly decreased biliary excretion of M2 and possibly to the increase
d amount of aldo-keto reductase in the liver, However, the increase in
the two aforementioned pharmacokinetic parameters in the case of M4 w
ere possibly due solely to the increased amount of aldo-keto reductase
in the liver.